Head AZ iLAB
Michael Kossenjans is a Principal Scientist within the Discovery Sciences unit at AstraZeneca Gothenburg, Sweden. He is currently leading a group of scientists focussing on the implementation of automation in early phase drug discovery.
Michael has been working with AstraZeneca since 2004. Before joining the Discovery Sciences unit in 2012 he occupied various roles in the Medicinal Chemistry department of the cardiovascular, renal and metabolic disease research area. Michael has been key in the discovery of a novel treatment of diabetic nephropathy and played a significant role in the build-up of AstraZeneca’s small molecule screening collection, among others through innovative compound exchange programs with peers.
Michael holds a PhD in organic chemistry and performed research in academic labs in Germany, Spain and the US before starting his industrial career at Sanofi in 2000.
Tuesday, January 28
4:00 PM – 4:30 PM